← Back to Clinical Trials
Recruiting NCT07883616

NCT07883616 Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07883616
Status Recruiting
Phase —
Sponsor Zagazig University
Condition Postoperative Pain After Spinal Surgery
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2025-10-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
MorphineBupivacaineDexamethasone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2025-10-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective randomized double-blind study aims to compare the efficacy of modified Thoracolumbar Interfascial Plane (mTLIP) block versus Retrolaminar block for postoperative pain control in patients undergoing elective two-level lumbar spine surgeries. The primary outcome is total morphine consumption in the first 24 postoperative hours.

Eligibility Criteria

Inclusion Criteria: * Age between 21 and 65 years * ASA physical status I or II * BMI \< 30 kg/m² * Scheduled for elective two-level lumbar spine surgery (discectomy/decompression) * Expected duration of surgery less than 3 hours * Patient's acceptance and written informed consent Exclusion Criteria: * Infection at block site * Known allergy to used drugs * Coagulation disorder * History of psychiatric illness * Pre-existing neurological deficits * Presence of any metastasis * Previous lumbar spine surgeries * Patients on previous opioid therapy

Contact & Investigator

Central Contact

Mohamed Shehta Mohamed Ali

✉ m.shehta025@medicine.zu.edu.eg

📞 +2001014634299

Principal Investigator

Mohamed Shehta Mohamed Ali, M.B.B.CH

PRINCIPAL INVESTIGATOR

Zagazig University

Frequently Asked Questions

Who can join the NCT07883616 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Postoperative Pain After Spinal Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07883616 currently recruiting?

Yes, NCT07883616 is actively recruiting participants. Contact the research team at m.shehta025@medicine.zu.edu.eg for enrollment information.

Where is the NCT07883616 trial being conducted?

This trial is being conducted at Zagazig, Egypt.

Who is sponsoring the NCT07883616 clinical trial?

NCT07883616 is sponsored by Zagazig University. The principal investigator is Mohamed Shehta Mohamed Ali, M.B.B.CH at Zagazig University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology